Annual Total Assets
$144.40 M
-$51.02 M-26.11%
31 December 2023
Summary:
Arbutus Biopharma annual total assets is currently $144.40 million, with the most recent change of -$51.02 million (-26.11%) on 31 December 2023. During the last 3 years, it has fallen by -$60.08 million (-29.38%). ABUS annual total assets is now -79.73% below its all-time high of $712.29 million, reached on 31 December 2015.ABUS Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Assets
$140.44 M
-$19.60 M-12.25%
30 September 2024
Summary:
Arbutus Biopharma quarterly total assets is currently $140.44 million, with the most recent change of -$19.60 million (-12.25%) on 30 September 2024. Over the past year, it has dropped by -$3.96 million (-2.74%). ABUS quarterly total assets is now -82.16% below its all-time high of $787.06 million, reached on 31 March 2015.ABUS Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABUS Total Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -2.7% |
| 3 y3 years | -29.4% | -31.3% |
| 5 y5 years | +36.8% | +33.1% |
ABUS Total Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -29.4% | at low | -40.7% | at low |
| 5 y | 5 years | -29.4% | +36.8% | -40.7% | +43.9% |
| alltime | all time | -79.7% | +2292.9% | -82.2% | +1264.5% |
Arbutus Biopharma Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $140.44 M(-12.2%) |
| June 2024 | - | $160.04 M(+6.5%) |
| Mar 2024 | - | $150.29 M(+4.1%) |
| Dec 2023 | $144.40 M(-26.1%) | $144.40 M(-9.0%) |
| Sept 2023 | - | $158.64 M(-10.3%) |
| June 2023 | - | $176.82 M(-7.5%) |
| Mar 2023 | - | $191.22 M(-2.1%) |
| Dec 2022 | $195.42 M(-4.4%) | $195.42 M(-4.1%) |
| Sept 2022 | - | $203.80 M(-5.6%) |
| June 2022 | - | $215.84 M(-8.9%) |
| Mar 2022 | - | $236.88 M(+15.8%) |
| Dec 2021 | $204.49 M(+49.2%) | $204.49 M(+23.5%) |
| Sept 2021 | - | $165.60 M(+22.3%) |
| June 2021 | - | $135.38 M(-7.4%) |
| Mar 2021 | - | $146.24 M(+6.7%) |
| Dec 2020 | $137.08 M(+29.9%) | $137.08 M(+4.6%) |
| Sept 2020 | - | $131.10 M(+34.3%) |
| June 2020 | - | $97.63 M(-4.9%) |
| Mar 2020 | - | $102.61 M(-2.8%) |
| Dec 2019 | $105.53 M(-53.7%) | $105.53 M(-10.0%) |
| Sept 2019 | - | $117.28 M(-39.1%) |
| June 2019 | - | $192.57 M(-8.0%) |
| Mar 2019 | - | $209.22 M(-8.2%) |
| Dec 2018 | $227.91 M(-3.9%) | $227.91 M(-7.1%) |
| Sept 2018 | - | $245.42 M(-11.4%) |
| June 2018 | - | $277.01 M(+2.6%) |
| Mar 2018 | - | $270.03 M(+13.9%) |
| Dec 2017 | $237.16 M(-14.0%) | $237.16 M(-1.1%) |
| Sept 2017 | - | $239.84 M(-6.0%) |
| June 2017 | - | $255.07 M(-4.9%) |
| Mar 2017 | - | $268.14 M(-2.8%) |
| Dec 2016 | $275.92 M(-61.3%) | $275.92 M(-46.4%) |
| Sept 2016 | - | $514.73 M(-3.0%) |
| June 2016 | - | $530.86 M(-24.5%) |
| Mar 2016 | - | $703.25 M(-1.3%) |
| Dec 2015 | $712.29 M(+502.7%) | $712.29 M(-1.4%) |
| Sept 2015 | - | $722.63 M(-6.6%) |
| June 2015 | - | $773.82 M(-1.7%) |
| Mar 2015 | - | $787.06 M(+566.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | $118.18 M(+64.8%) | $118.18 M(-5.5%) |
| Sept 2014 | - | $125.06 M(-5.3%) |
| June 2014 | - | $132.07 M(-4.7%) |
| Mar 2014 | - | $138.52 M(+93.2%) |
| Dec 2013 | $71.72 M(+36.4%) | $71.72 M(+65.3%) |
| Sept 2013 | - | $43.38 M(-5.5%) |
| June 2013 | - | $45.91 M(-9.1%) |
| Mar 2013 | - | $50.50 M(-4.0%) |
| Dec 2012 | $52.60 M(+283.8%) | $52.60 M(+411.0%) |
| Sept 2012 | - | $10.29 M(-11.5%) |
| June 2012 | - | $11.63 M(-20.8%) |
| Mar 2012 | - | $14.69 M(+7.2%) |
| Dec 2011 | $13.70 M(-34.8%) | $13.70 M(-7.8%) |
| Sept 2011 | - | $14.86 M(-22.0%) |
| June 2011 | - | $19.05 M(+9.5%) |
| Mar 2011 | - | $17.41 M(-17.2%) |
| Dec 2010 | $21.02 M(-24.8%) | $21.02 M(-40.3%) |
| Sept 2010 | - | $35.22 M(-0.4%) |
| June 2010 | - | $35.36 M(-4.5%) |
| Mar 2010 | - | $37.05 M(+32.5%) |
| Dec 2009 | $27.96 M(-34.0%) | $27.96 M(-35.6%) |
| Sept 2009 | - | $43.45 M(+4.3%) |
| June 2009 | - | $41.65 M(+4.9%) |
| Mar 2009 | - | $39.71 M(-6.2%) |
| Dec 2008 | $42.34 M(+70.5%) | $42.34 M(-18.8%) |
| Sept 2008 | - | $52.15 M(-16.1%) |
| June 2008 | - | $62.19 M(+180.0%) |
| Mar 2008 | - | $22.21 M(-10.6%) |
| Dec 2007 | $24.83 M(+311.5%) | $24.83 M(-4.0%) |
| Sept 2007 | - | $25.87 M(+3.7%) |
| June 2007 | - | $24.96 M |
| Dec 2006 | $6.03 M(-67.4%) | - |
| Dec 2005 | $18.50 M(-55.0%) | - |
| Dec 2004 | $41.10 M(-19.0%) | - |
| Dec 2003 | $50.73 M(-4.7%) | - |
| Dec 2002 | $53.23 M(-21.3%) | - |
| Dec 2001 | $67.60 M(+107.9%) | - |
| Dec 2000 | $32.52 M(+12.9%) | - |
| Dec 1999 | $28.80 M(+81.9%) | - |
| Dec 1998 | $15.83 M | - |
FAQ
- What is Arbutus Biopharma annual total assets?
- What is the all time high annual total assets for Arbutus Biopharma?
- What is Arbutus Biopharma quarterly total assets?
- What is the all time high quarterly total assets for Arbutus Biopharma?
- What is Arbutus Biopharma quarterly total assets year-on-year change?
What is Arbutus Biopharma annual total assets?
The current annual total assets of ABUS is $144.40 M
What is the all time high annual total assets for Arbutus Biopharma?
Arbutus Biopharma all-time high annual total assets is $712.29 M
What is Arbutus Biopharma quarterly total assets?
The current quarterly total assets of ABUS is $140.44 M
What is the all time high quarterly total assets for Arbutus Biopharma?
Arbutus Biopharma all-time high quarterly total assets is $787.06 M
What is Arbutus Biopharma quarterly total assets year-on-year change?
Over the past year, ABUS quarterly total assets has changed by -$3.96 M (-2.74%)